Exelixis (EXEL) EBT (2010 - 2026)

Exelixis' EBT history runs 17 years deep, the most recent figure standing at $267.7 million for Q2 2026.

• In Q2 2026, EBT rose 30.14% year-over-year to $267.7 million; the TTM figure through Apr 2026 stood at $1.0 billion (up 19.7% YoY), while the FY2026 annual figure was $941.2 million, up 38.08% from the prior year.
• EBT for Q2 2026 stood at $267.7 million, up from $252.7 million in the prior quarter.
• The five-year high for EBT was $292.8 million in Q2 2024, with the low at -$31.4 million in Q4 2022.
• The 5-year median for EBT is $103.0 million (2023), against an average of $140.1 million.
• Peak annual rise in EBT reached 4329.73% in 2022, while the deepest fall reached 126.63% in 2022.
• Exelixis' EBT stood at -$31.4 million in 2022, then jumped by 427.87% to $103.0 million in 2023, then surged by 50.19% to $154.8 million in 2024, then jumped by 63.1% to $252.4 million in 2025, then advanced by 6.05% to $267.7 million in 2026.
• Business Quant data shows EXEL's EBT at $267.7 million in Q2 2026, $252.7 million in Q1 2026, and $252.4 million in Q4 2025.